unconjugated ng2 Search Results


95
Vector Laboratories rabbit anti ng2
a, The sensitivities of the indicated HeLa KO cells to TcdB and TcdB 1-1830 were quantified using the cytopathic cell-rounding assay (see ) and normalized to WT HeLa cells as fold-of-resistance. The experiments have been repeated three times. b–c, Immunostaining analysis showed that TcdB binding (10 nM, 10 min) to CSPG4 −/− cells was reduced ( b ). Ectopic expression of <t>NG2</t> (rat CSPG4) increased binding of TcdB. Transfection of FZD2 also increased TcdB binding to CSPG4 −/− cells ( c ). Scale bar = 20 μm. DIC: differential interference contrast. d, Ectopic expression of CSPG4 or FZD2 restored TcdB entry into CSPG4 −/− cells, resulting in cell-rounding (5 pM, 3 h). GFP marked transfected cells. Scale bar = 50 μm. e, A schematic illustration of FZD (upper panel). Fc-tagged FZD2-CRD binds to GST-tagged TcdB 1501-2366 , but not to GST-tagged CROPs. f–g, FZD2-CRD prevented TcdB (300 pM, 3 h) entry into CSPG4 −/− cells, measured by the cell-rounding assay ( f ) and glucosylation of Rac1 ( g ). Human IgG1-Fc (hIgG1-Fc) is a control. h, Transfection of FZD1, 2, and 7 each increased TcdB binding (10 nM, 10 min) to CSPG4 −/− cells, assayed by immunoblot analysis of cell lysates. Actin is a loading control. i, The sensitivities of FZD1 −/− , FZD2 −/− , FZD7 −/− , and FZD1/2/7 −/− cells to TcdB and TcdB 1-1830 were analyzed as described in panel a. j, Ectopic expression of FZD1, 2, or 7 restored TcdB 1-1830 entry into FZD1/2/7 −/− cells (300 pM, 3 h). Scale bar = 50 μm. k, Characterization of TcdB binding to Fc-tagged CRDs of FZD1, 2, 5, and 7 using the bio-layer interferometry (BLI) assay (see for K D analysis). Representative images are from one of three independent experiments. Error bars indicate mean ± s.d., n = 6, *P < 0.005, t -test.
Rabbit Anti Ng2, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/unconjugated+ng2/pmc05519134-219-28-42?v=Vector+Laboratories
Average 95 stars, based on 1 article reviews
rabbit anti ng2 - by Bioz Stars, 2026-08
95/100 stars
  Buy from Supplier

94
Santa Cruz Biotechnology unconjugated anti ng2 antibody
a, The sensitivities of the indicated HeLa KO cells to TcdB and TcdB 1-1830 were quantified using the cytopathic cell-rounding assay (see ) and normalized to WT HeLa cells as fold-of-resistance. The experiments have been repeated three times. b–c, Immunostaining analysis showed that TcdB binding (10 nM, 10 min) to CSPG4 −/− cells was reduced ( b ). Ectopic expression of <t>NG2</t> (rat CSPG4) increased binding of TcdB. Transfection of FZD2 also increased TcdB binding to CSPG4 −/− cells ( c ). Scale bar = 20 μm. DIC: differential interference contrast. d, Ectopic expression of CSPG4 or FZD2 restored TcdB entry into CSPG4 −/− cells, resulting in cell-rounding (5 pM, 3 h). GFP marked transfected cells. Scale bar = 50 μm. e, A schematic illustration of FZD (upper panel). Fc-tagged FZD2-CRD binds to GST-tagged TcdB 1501-2366 , but not to GST-tagged CROPs. f–g, FZD2-CRD prevented TcdB (300 pM, 3 h) entry into CSPG4 −/− cells, measured by the cell-rounding assay ( f ) and glucosylation of Rac1 ( g ). Human IgG1-Fc (hIgG1-Fc) is a control. h, Transfection of FZD1, 2, and 7 each increased TcdB binding (10 nM, 10 min) to CSPG4 −/− cells, assayed by immunoblot analysis of cell lysates. Actin is a loading control. i, The sensitivities of FZD1 −/− , FZD2 −/− , FZD7 −/− , and FZD1/2/7 −/− cells to TcdB and TcdB 1-1830 were analyzed as described in panel a. j, Ectopic expression of FZD1, 2, or 7 restored TcdB 1-1830 entry into FZD1/2/7 −/− cells (300 pM, 3 h). Scale bar = 50 μm. k, Characterization of TcdB binding to Fc-tagged CRDs of FZD1, 2, 5, and 7 using the bio-layer interferometry (BLI) assay (see for K D analysis). Representative images are from one of three independent experiments. Error bars indicate mean ± s.d., n = 6, *P < 0.005, t -test.
Unconjugated Anti Ng2 Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/unconjugated+ng2/pm27252423-150-15-18?v=Santa+Cruz+Biotechnology
Average 94 stars, based on 1 article reviews
unconjugated anti ng2 antibody - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier

93
Biorbyt anti ng2
a, The sensitivities of the indicated HeLa KO cells to TcdB and TcdB 1-1830 were quantified using the cytopathic cell-rounding assay (see ) and normalized to WT HeLa cells as fold-of-resistance. The experiments have been repeated three times. b–c, Immunostaining analysis showed that TcdB binding (10 nM, 10 min) to CSPG4 −/− cells was reduced ( b ). Ectopic expression of <t>NG2</t> (rat CSPG4) increased binding of TcdB. Transfection of FZD2 also increased TcdB binding to CSPG4 −/− cells ( c ). Scale bar = 20 μm. DIC: differential interference contrast. d, Ectopic expression of CSPG4 or FZD2 restored TcdB entry into CSPG4 −/− cells, resulting in cell-rounding (5 pM, 3 h). GFP marked transfected cells. Scale bar = 50 μm. e, A schematic illustration of FZD (upper panel). Fc-tagged FZD2-CRD binds to GST-tagged TcdB 1501-2366 , but not to GST-tagged CROPs. f–g, FZD2-CRD prevented TcdB (300 pM, 3 h) entry into CSPG4 −/− cells, measured by the cell-rounding assay ( f ) and glucosylation of Rac1 ( g ). Human IgG1-Fc (hIgG1-Fc) is a control. h, Transfection of FZD1, 2, and 7 each increased TcdB binding (10 nM, 10 min) to CSPG4 −/− cells, assayed by immunoblot analysis of cell lysates. Actin is a loading control. i, The sensitivities of FZD1 −/− , FZD2 −/− , FZD7 −/− , and FZD1/2/7 −/− cells to TcdB and TcdB 1-1830 were analyzed as described in panel a. j, Ectopic expression of FZD1, 2, or 7 restored TcdB 1-1830 entry into FZD1/2/7 −/− cells (300 pM, 3 h). Scale bar = 50 μm. k, Characterization of TcdB binding to Fc-tagged CRDs of FZD1, 2, 5, and 7 using the bio-layer interferometry (BLI) assay (see for K D analysis). Representative images are from one of three independent experiments. Error bars indicate mean ± s.d., n = 6, *P < 0.005, t -test.
Anti Ng2, supplied by Biorbyt, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/unconjugated+ng2/ppr0366563-127-31-33?v=Biorbyt
Average 93 stars, based on 1 article reviews
anti ng2 - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

94
Proteintech protein tau tau
a, The sensitivities of the indicated HeLa KO cells to TcdB and TcdB 1-1830 were quantified using the cytopathic cell-rounding assay (see ) and normalized to WT HeLa cells as fold-of-resistance. The experiments have been repeated three times. b–c, Immunostaining analysis showed that TcdB binding (10 nM, 10 min) to CSPG4 −/− cells was reduced ( b ). Ectopic expression of <t>NG2</t> (rat CSPG4) increased binding of TcdB. Transfection of FZD2 also increased TcdB binding to CSPG4 −/− cells ( c ). Scale bar = 20 μm. DIC: differential interference contrast. d, Ectopic expression of CSPG4 or FZD2 restored TcdB entry into CSPG4 −/− cells, resulting in cell-rounding (5 pM, 3 h). GFP marked transfected cells. Scale bar = 50 μm. e, A schematic illustration of FZD (upper panel). Fc-tagged FZD2-CRD binds to GST-tagged TcdB 1501-2366 , but not to GST-tagged CROPs. f–g, FZD2-CRD prevented TcdB (300 pM, 3 h) entry into CSPG4 −/− cells, measured by the cell-rounding assay ( f ) and glucosylation of Rac1 ( g ). Human IgG1-Fc (hIgG1-Fc) is a control. h, Transfection of FZD1, 2, and 7 each increased TcdB binding (10 nM, 10 min) to CSPG4 −/− cells, assayed by immunoblot analysis of cell lysates. Actin is a loading control. i, The sensitivities of FZD1 −/− , FZD2 −/− , FZD7 −/− , and FZD1/2/7 −/− cells to TcdB and TcdB 1-1830 were analyzed as described in panel a. j, Ectopic expression of FZD1, 2, or 7 restored TcdB 1-1830 entry into FZD1/2/7 −/− cells (300 pM, 3 h). Scale bar = 50 μm. k, Characterization of TcdB binding to Fc-tagged CRDs of FZD1, 2, 5, and 7 using the bio-layer interferometry (BLI) assay (see for K D analysis). Representative images are from one of three independent experiments. Error bars indicate mean ± s.d., n = 6, *P < 0.005, t -test.
Protein Tau Tau, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/unconjugated+ng2/pmc10086924-149-66-78?v=Proteintech
Average 94 stars, based on 1 article reviews
protein tau tau - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier

96
Vector Laboratories goat anti mouse igg
a, The sensitivities of the indicated HeLa KO cells to TcdB and TcdB 1-1830 were quantified using the cytopathic cell-rounding assay (see ) and normalized to WT HeLa cells as fold-of-resistance. The experiments have been repeated three times. b–c, Immunostaining analysis showed that TcdB binding (10 nM, 10 min) to CSPG4 −/− cells was reduced ( b ). Ectopic expression of <t>NG2</t> (rat CSPG4) increased binding of TcdB. Transfection of FZD2 also increased TcdB binding to CSPG4 −/− cells ( c ). Scale bar = 20 μm. DIC: differential interference contrast. d, Ectopic expression of CSPG4 or FZD2 restored TcdB entry into CSPG4 −/− cells, resulting in cell-rounding (5 pM, 3 h). GFP marked transfected cells. Scale bar = 50 μm. e, A schematic illustration of FZD (upper panel). Fc-tagged FZD2-CRD binds to GST-tagged TcdB 1501-2366 , but not to GST-tagged CROPs. f–g, FZD2-CRD prevented TcdB (300 pM, 3 h) entry into CSPG4 −/− cells, measured by the cell-rounding assay ( f ) and glucosylation of Rac1 ( g ). Human IgG1-Fc (hIgG1-Fc) is a control. h, Transfection of FZD1, 2, and 7 each increased TcdB binding (10 nM, 10 min) to CSPG4 −/− cells, assayed by immunoblot analysis of cell lysates. Actin is a loading control. i, The sensitivities of FZD1 −/− , FZD2 −/− , FZD7 −/− , and FZD1/2/7 −/− cells to TcdB and TcdB 1-1830 were analyzed as described in panel a. j, Ectopic expression of FZD1, 2, or 7 restored TcdB 1-1830 entry into FZD1/2/7 −/− cells (300 pM, 3 h). Scale bar = 50 μm. k, Characterization of TcdB binding to Fc-tagged CRDs of FZD1, 2, 5, and 7 using the bio-layer interferometry (BLI) assay (see for K D analysis). Representative images are from one of three independent experiments. Error bars indicate mean ± s.d., n = 6, *P < 0.005, t -test.
Goat Anti Mouse Igg, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/unconjugated+ng2/pmc02706586-129-16-35?v=Vector+Laboratories
Average 96 stars, based on 1 article reviews
goat anti mouse igg - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier

96
Vector Laboratories fitc conjugated goat anti rabbit igg
a, The sensitivities of the indicated HeLa KO cells to TcdB and TcdB 1-1830 were quantified using the cytopathic cell-rounding assay (see ) and normalized to WT HeLa cells as fold-of-resistance. The experiments have been repeated three times. b–c, Immunostaining analysis showed that TcdB binding (10 nM, 10 min) to CSPG4 −/− cells was reduced ( b ). Ectopic expression of <t>NG2</t> (rat CSPG4) increased binding of TcdB. Transfection of FZD2 also increased TcdB binding to CSPG4 −/− cells ( c ). Scale bar = 20 μm. DIC: differential interference contrast. d, Ectopic expression of CSPG4 or FZD2 restored TcdB entry into CSPG4 −/− cells, resulting in cell-rounding (5 pM, 3 h). GFP marked transfected cells. Scale bar = 50 μm. e, A schematic illustration of FZD (upper panel). Fc-tagged FZD2-CRD binds to GST-tagged TcdB 1501-2366 , but not to GST-tagged CROPs. f–g, FZD2-CRD prevented TcdB (300 pM, 3 h) entry into CSPG4 −/− cells, measured by the cell-rounding assay ( f ) and glucosylation of Rac1 ( g ). Human IgG1-Fc (hIgG1-Fc) is a control. h, Transfection of FZD1, 2, and 7 each increased TcdB binding (10 nM, 10 min) to CSPG4 −/− cells, assayed by immunoblot analysis of cell lysates. Actin is a loading control. i, The sensitivities of FZD1 −/− , FZD2 −/− , FZD7 −/− , and FZD1/2/7 −/− cells to TcdB and TcdB 1-1830 were analyzed as described in panel a. j, Ectopic expression of FZD1, 2, or 7 restored TcdB 1-1830 entry into FZD1/2/7 −/− cells (300 pM, 3 h). Scale bar = 50 μm. k, Characterization of TcdB binding to Fc-tagged CRDs of FZD1, 2, 5, and 7 using the bio-layer interferometry (BLI) assay (see for K D analysis). Representative images are from one of three independent experiments. Error bars indicate mean ± s.d., n = 6, *P < 0.005, t -test.
Fitc Conjugated Goat Anti Rabbit Igg, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/unconjugated+ng2/pm16126908-39-14-29?v=Vector+Laboratories
Average 96 stars, based on 1 article reviews
fitc conjugated goat anti rabbit igg - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier

96
Vector Laboratories rabbit antibody against rat ng2
a, The sensitivities of the indicated HeLa KO cells to TcdB and TcdB 1-1830 were quantified using the cytopathic cell-rounding assay (see ) and normalized to WT HeLa cells as fold-of-resistance. The experiments have been repeated three times. b–c, Immunostaining analysis showed that TcdB binding (10 nM, 10 min) to CSPG4 −/− cells was reduced ( b ). Ectopic expression of <t>NG2</t> (rat CSPG4) increased binding of TcdB. Transfection of FZD2 also increased TcdB binding to CSPG4 −/− cells ( c ). Scale bar = 20 μm. DIC: differential interference contrast. d, Ectopic expression of CSPG4 or FZD2 restored TcdB entry into CSPG4 −/− cells, resulting in cell-rounding (5 pM, 3 h). GFP marked transfected cells. Scale bar = 50 μm. e, A schematic illustration of FZD (upper panel). Fc-tagged FZD2-CRD binds to GST-tagged TcdB 1501-2366 , but not to GST-tagged CROPs. f–g, FZD2-CRD prevented TcdB (300 pM, 3 h) entry into CSPG4 −/− cells, measured by the cell-rounding assay ( f ) and glucosylation of Rac1 ( g ). Human IgG1-Fc (hIgG1-Fc) is a control. h, Transfection of FZD1, 2, and 7 each increased TcdB binding (10 nM, 10 min) to CSPG4 −/− cells, assayed by immunoblot analysis of cell lysates. Actin is a loading control. i, The sensitivities of FZD1 −/− , FZD2 −/− , FZD7 −/− , and FZD1/2/7 −/− cells to TcdB and TcdB 1-1830 were analyzed as described in panel a. j, Ectopic expression of FZD1, 2, or 7 restored TcdB 1-1830 entry into FZD1/2/7 −/− cells (300 pM, 3 h). Scale bar = 50 μm. k, Characterization of TcdB binding to Fc-tagged CRDs of FZD1, 2, 5, and 7 using the bio-layer interferometry (BLI) assay (see for K D analysis). Representative images are from one of three independent experiments. Error bars indicate mean ± s.d., n = 6, *P < 0.005, t -test.
Rabbit Antibody Against Rat Ng2, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/unconjugated+ng2/pm16625365-28-6-34?v=Vector+Laboratories
Average 96 stars, based on 1 article reviews
rabbit antibody against rat ng2 - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier

N/A
The NG2 MCSP Antibody 7G4E5 from Novus Biologicals is a mouse monoclonal antibody to NG2 MCSP This antibody reacts with human The NG2 MCSP Antibody 7G4E5 has been validated for the following applications Western Blot
  Buy from Supplier

N/A
The Human NG2 MCSP Antibody from R D Systems is a mouse monoclonal antibody to NG2 MCSP This antibody reacts with human The Human NG2 MCSP Antibody has been validated for the following applications Western
  Buy from Supplier

N/A
The Recombinant Human NG2 MCSP CSPG4 Protein from R D Systems is derived from NS0 The Recombinant Human NG2 MCSP CSPG4 Protein has been validated for the following applications Bioactivity
  Buy from Supplier

N/A
Rat polyclonal antibody to Nidogen/EnactinG2 Domain Isotype Note: IgG2b Host Note: Rat Conjugation Note: Unconjugated Reactivity Note: Mouse Application Note: ELISA, WB
  Buy from Supplier

N/A
Mouse monoclonal antibody to FABP 2-coating Host Note: Mouse Conjugation Note: Unconjugated Application Note: ELISA, Lateral flow
  Buy from Supplier

Image Search Results


a, The sensitivities of the indicated HeLa KO cells to TcdB and TcdB 1-1830 were quantified using the cytopathic cell-rounding assay (see ) and normalized to WT HeLa cells as fold-of-resistance. The experiments have been repeated three times. b–c, Immunostaining analysis showed that TcdB binding (10 nM, 10 min) to CSPG4 −/− cells was reduced ( b ). Ectopic expression of NG2 (rat CSPG4) increased binding of TcdB. Transfection of FZD2 also increased TcdB binding to CSPG4 −/− cells ( c ). Scale bar = 20 μm. DIC: differential interference contrast. d, Ectopic expression of CSPG4 or FZD2 restored TcdB entry into CSPG4 −/− cells, resulting in cell-rounding (5 pM, 3 h). GFP marked transfected cells. Scale bar = 50 μm. e, A schematic illustration of FZD (upper panel). Fc-tagged FZD2-CRD binds to GST-tagged TcdB 1501-2366 , but not to GST-tagged CROPs. f–g, FZD2-CRD prevented TcdB (300 pM, 3 h) entry into CSPG4 −/− cells, measured by the cell-rounding assay ( f ) and glucosylation of Rac1 ( g ). Human IgG1-Fc (hIgG1-Fc) is a control. h, Transfection of FZD1, 2, and 7 each increased TcdB binding (10 nM, 10 min) to CSPG4 −/− cells, assayed by immunoblot analysis of cell lysates. Actin is a loading control. i, The sensitivities of FZD1 −/− , FZD2 −/− , FZD7 −/− , and FZD1/2/7 −/− cells to TcdB and TcdB 1-1830 were analyzed as described in panel a. j, Ectopic expression of FZD1, 2, or 7 restored TcdB 1-1830 entry into FZD1/2/7 −/− cells (300 pM, 3 h). Scale bar = 50 μm. k, Characterization of TcdB binding to Fc-tagged CRDs of FZD1, 2, 5, and 7 using the bio-layer interferometry (BLI) assay (see for K D analysis). Representative images are from one of three independent experiments. Error bars indicate mean ± s.d., n = 6, *P < 0.005, t -test.

Journal: Nature

Article Title: Frizzled are colonic epithelial receptors for Clostridium difficile toxin B

doi: 10.1038/nature19799

Figure Lengend Snippet: a, The sensitivities of the indicated HeLa KO cells to TcdB and TcdB 1-1830 were quantified using the cytopathic cell-rounding assay (see ) and normalized to WT HeLa cells as fold-of-resistance. The experiments have been repeated three times. b–c, Immunostaining analysis showed that TcdB binding (10 nM, 10 min) to CSPG4 −/− cells was reduced ( b ). Ectopic expression of NG2 (rat CSPG4) increased binding of TcdB. Transfection of FZD2 also increased TcdB binding to CSPG4 −/− cells ( c ). Scale bar = 20 μm. DIC: differential interference contrast. d, Ectopic expression of CSPG4 or FZD2 restored TcdB entry into CSPG4 −/− cells, resulting in cell-rounding (5 pM, 3 h). GFP marked transfected cells. Scale bar = 50 μm. e, A schematic illustration of FZD (upper panel). Fc-tagged FZD2-CRD binds to GST-tagged TcdB 1501-2366 , but not to GST-tagged CROPs. f–g, FZD2-CRD prevented TcdB (300 pM, 3 h) entry into CSPG4 −/− cells, measured by the cell-rounding assay ( f ) and glucosylation of Rac1 ( g ). Human IgG1-Fc (hIgG1-Fc) is a control. h, Transfection of FZD1, 2, and 7 each increased TcdB binding (10 nM, 10 min) to CSPG4 −/− cells, assayed by immunoblot analysis of cell lysates. Actin is a loading control. i, The sensitivities of FZD1 −/− , FZD2 −/− , FZD7 −/− , and FZD1/2/7 −/− cells to TcdB and TcdB 1-1830 were analyzed as described in panel a. j, Ectopic expression of FZD1, 2, or 7 restored TcdB 1-1830 entry into FZD1/2/7 −/− cells (300 pM, 3 h). Scale bar = 50 μm. k, Characterization of TcdB binding to Fc-tagged CRDs of FZD1, 2, 5, and 7 using the bio-layer interferometry (BLI) assay (see for K D analysis). Representative images are from one of three independent experiments. Error bars indicate mean ± s.d., n = 6, *P < 0.005, t -test.

Article Snippet: The colonic sections were then blocked with 5% goat serum in PBS for 30 min at room temperature and incubated with primary antibodies overnight (anti-TcdB: 1:600; anti-FZDs: 1:250; rabbit anti-NG2: 1:250), followed with biotinylated goat anti-chicken or rabbit IgG secondary antibodies (1:200, Vector Lab) for 1 h at room temperature.

Techniques: Immunostaining, Binding Assay, Expressing, Transfection, Western Blot

a, Schematic drawings of NG2 (rat CSPG4). Two fractions of recombinant extracellular domain (EC) fragments were used: one that does not contain chondroitin sulfate (CS) chains (EC P1), and the other that contains CS (EC P2). TMD-cyto: transmembrane and cytoplasmic domain. b, TcdB, but not TcdB 1-1830 , binds directly to both EC P1 and EC P2 of NG2 in a microtiter plate-based binding assay (error bars indicate mean ± s.d., two independent experiments). c, CSPG4 −/− cells transfected with the indicated constructs were exposed to TcdB (10 nM), TcdB 1-1830 (10 nM), or the receptor-binding domain of botulinum neurotoxin B (BoNT/B, 100 nM) for 10 min. Cell lysates were collected and subjected to immunoblot analysis. IL1RAPL2 and synaptotagmin II (Syt II, a receptor for BoNT/B) served as controls. Transfection of NG2 increased binding of TcdB, but not TcdB 1-1830 , whereas transfection of FZD2 increased binding of both TcdB and TcdB 1-1830 . One of three independent experiments is shown. d, The CROPs domain binds to CSPG4 on cell surfaces in a dose-dependent manner. High concentrations of recombinant CROPs reduced CSPG4-dependent binding of TcdB to cell surfaces, indicating that the CROPs can compete with TcdB for binding to CSPG4 on cell surfaces. One of three independent experiments is shown. e, The CROPs domain reduced cytopathic toxicity of TcdB (5 pM) on WT HeLa cells (error bars indicate mean ± s.d., two independent experiments). f, CSPG4 −/− cells were transfected with FZD2 and then exposed to TcdB or indicated TcdB fragments. FZD2 mediated binding of TcdB, TcdB 1-1830 , and TcdB 1501-2366 , but not the CROPs (TcdB 1831-2366 ). One of three independent experiments is shown.

Journal: Nature

Article Title: Frizzled are colonic epithelial receptors for Clostridium difficile toxin B

doi: 10.1038/nature19799

Figure Lengend Snippet: a, Schematic drawings of NG2 (rat CSPG4). Two fractions of recombinant extracellular domain (EC) fragments were used: one that does not contain chondroitin sulfate (CS) chains (EC P1), and the other that contains CS (EC P2). TMD-cyto: transmembrane and cytoplasmic domain. b, TcdB, but not TcdB 1-1830 , binds directly to both EC P1 and EC P2 of NG2 in a microtiter plate-based binding assay (error bars indicate mean ± s.d., two independent experiments). c, CSPG4 −/− cells transfected with the indicated constructs were exposed to TcdB (10 nM), TcdB 1-1830 (10 nM), or the receptor-binding domain of botulinum neurotoxin B (BoNT/B, 100 nM) for 10 min. Cell lysates were collected and subjected to immunoblot analysis. IL1RAPL2 and synaptotagmin II (Syt II, a receptor for BoNT/B) served as controls. Transfection of NG2 increased binding of TcdB, but not TcdB 1-1830 , whereas transfection of FZD2 increased binding of both TcdB and TcdB 1-1830 . One of three independent experiments is shown. d, The CROPs domain binds to CSPG4 on cell surfaces in a dose-dependent manner. High concentrations of recombinant CROPs reduced CSPG4-dependent binding of TcdB to cell surfaces, indicating that the CROPs can compete with TcdB for binding to CSPG4 on cell surfaces. One of three independent experiments is shown. e, The CROPs domain reduced cytopathic toxicity of TcdB (5 pM) on WT HeLa cells (error bars indicate mean ± s.d., two independent experiments). f, CSPG4 −/− cells were transfected with FZD2 and then exposed to TcdB or indicated TcdB fragments. FZD2 mediated binding of TcdB, TcdB 1-1830 , and TcdB 1501-2366 , but not the CROPs (TcdB 1831-2366 ). One of three independent experiments is shown.

Article Snippet: The colonic sections were then blocked with 5% goat serum in PBS for 30 min at room temperature and incubated with primary antibodies overnight (anti-TcdB: 1:600; anti-FZDs: 1:250; rabbit anti-NG2: 1:250), followed with biotinylated goat anti-chicken or rabbit IgG secondary antibodies (1:200, Vector Lab) for 1 h at room temperature.

Techniques: Recombinant, Binding Assay, Transfection, Construct, Western Blot

a, NG2-EC was immobilized on microtiter plates, followed by binding of TcdB, washing away unbound TcdB, and addition of FZD-CRD. FZD2-CRD binds robustly to TcdB that is pre-bound by NG2-EC on the microtiter plate. FZD2-CRD did not bind to NG2-EC without TcdB, and FZD5-CRD showed no detectable binding to NG2-TcdB in this assay (error bars indicate mean ± s.d., two independent experiments). b, Experiments are described in on HeLa (5 pM TcdB), HT-29 (50 pM TcdB), and Caco-2 cells (150 pM TcdB). Scale bars = 50 μm (HeLa and Caco-2) or 25 μm (HT-29). Representative images are from one of four independent experiments.

Journal: Nature

Article Title: Frizzled are colonic epithelial receptors for Clostridium difficile toxin B

doi: 10.1038/nature19799

Figure Lengend Snippet: a, NG2-EC was immobilized on microtiter plates, followed by binding of TcdB, washing away unbound TcdB, and addition of FZD-CRD. FZD2-CRD binds robustly to TcdB that is pre-bound by NG2-EC on the microtiter plate. FZD2-CRD did not bind to NG2-EC without TcdB, and FZD5-CRD showed no detectable binding to NG2-TcdB in this assay (error bars indicate mean ± s.d., two independent experiments). b, Experiments are described in on HeLa (5 pM TcdB), HT-29 (50 pM TcdB), and Caco-2 cells (150 pM TcdB). Scale bars = 50 μm (HeLa and Caco-2) or 25 μm (HT-29). Representative images are from one of four independent experiments.

Article Snippet: The colonic sections were then blocked with 5% goat serum in PBS for 30 min at room temperature and incubated with primary antibodies overnight (anti-TcdB: 1:600; anti-FZDs: 1:250; rabbit anti-NG2: 1:250), followed with biotinylated goat anti-chicken or rabbit IgG secondary antibodies (1:200, Vector Lab) for 1 h at room temperature.

Techniques: Binding Assay

a–b, FZD2-CRD protected HT-29 ( a ) and Caco-2 cells ( b ) from TcdB 1-1830 (300 pM, 3 h). Representative images are from one of three independent experiments. Scale bars = 25 μm ( a ) or 50 μm ( b ). c, Expression of CSPG4 in HeLa, HT-29, and Caco-2 cells was examined via immunoblot analysis of cell lysates. One experiment from four is shown. d, Protection from TcdB using FZD2-CRD and NG2-EC on HeLa (5 pM TcdB), HT-29 (50 pM TcdB), and Caco-2 (150 pM TcdB) cells was quantified by the cytopathic cell-rounding assay. Representative images are shown in . Error bars indicate mean ± s.d..

Journal: Nature

Article Title: Frizzled are colonic epithelial receptors for Clostridium difficile toxin B

doi: 10.1038/nature19799

Figure Lengend Snippet: a–b, FZD2-CRD protected HT-29 ( a ) and Caco-2 cells ( b ) from TcdB 1-1830 (300 pM, 3 h). Representative images are from one of three independent experiments. Scale bars = 25 μm ( a ) or 50 μm ( b ). c, Expression of CSPG4 in HeLa, HT-29, and Caco-2 cells was examined via immunoblot analysis of cell lysates. One experiment from four is shown. d, Protection from TcdB using FZD2-CRD and NG2-EC on HeLa (5 pM TcdB), HT-29 (50 pM TcdB), and Caco-2 (150 pM TcdB) cells was quantified by the cytopathic cell-rounding assay. Representative images are shown in . Error bars indicate mean ± s.d..

Article Snippet: The colonic sections were then blocked with 5% goat serum in PBS for 30 min at room temperature and incubated with primary antibodies overnight (anti-TcdB: 1:600; anti-FZDs: 1:250; rabbit anti-NG2: 1:250), followed with biotinylated goat anti-chicken or rabbit IgG secondary antibodies (1:200, Vector Lab) for 1 h at room temperature.

Techniques: Expressing, Western Blot